The chemical substance with the name "(5R,8S,9S,10R,13S,14S)-4-diazonio-17-[(2R)-1-hydroxypropan-2-yl]-10,13-dimethyl-2,5,6,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-3-olate" and CAS number "74850-10-5" is a complex organic compound characterized by its multi-ring structure, which is typical of steroid-like molecules. It features a diazonium group, which indicates it may participate in electrophilic reactions, and a hydroxyl group that suggests potential for hydrogen bonding and solubility in polar solvents. The stereochemistry is specified by the R and S designations, indicating the presence of multiple chiral centers, which can influence the compound's biological activity and interactions. This compound may exhibit properties relevant to medicinal chemistry, particularly in the context of hormone-like activity or as a precursor in synthetic pathways. Its intricate structure and functional groups suggest potential applications in pharmaceuticals or biochemistry, although specific biological activities would require further investigation.

RMI-18341 is a Testosterone 5 alpha reductase inhibitor.

(5R,8S,9S,10R,13S,14S)-4-diazonio-17-[(2R)-1-hydroxypropan-2-yl]-10,13-dimethyl-2,5,6,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-3-olate (non-preferred name)

74850-10-5: The chemical substance with the name "(5R,8S,9S,10R,13S,14S)-4-diazonio-17-[(2R)-1-hydroxypropan-2-yl]-10,13-dimethyl-2,5,6,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-3-olate" and CAS number "74850-10-5" is a complex organic compound characterized by its multi-ring structure, which is typical of steroid-like molecules. It features a diazonium group, which indicates it may participate in electrophilic reactions, and a hydroxyl group that suggests potential for hydrogen bonding and solubility in polar solvents. The stereochemistry is specified by the R and S designations, indicating the presence of multiple chiral centers, which can influence the compound's biological activity and interactions. This compound may exhibit properties relevant to medicinal chemistry, particularly in the context of hormone-like activity or as a precursor in synthetic pathways. Its intricate structure and functional groups suggest potential applications in pharmaceuticals or biochemistry, although specific biological activities would require further investigation.

CAS 74850-10-5

(5R,8S,9S,10R,13S,14S)-4-diazonio-17-[(2R)-1-hydroxypropan-2-yl]-10,13-dimethyl-2,5,6,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-3-olate (non-preferred name)

RMI-18341

Ref: TM-T68757